dexamethasone
UkraineDrugs containing this active substance
-
The drug is used to treat acute otitis externa and acute otitis media (if there is drainage through a tube in the tympanic membrane) caused by bacteria sensitive to it.
Form: drops, otic suspension
Active substance Dosage ciprofloxacin 3.0 mg/ml dexamethasone 1.0 mg/ml ATC: S02CA06
Manufacturer: Farmak JSC
-
The drug is used to treat acute otitis externa, as well as acute otitis media (if there is drainage through a tube), caused by antibiotic-sensitive bacteria. It is also prescribed for inflammatory eye diseases if there is a superficial bacterial infection.
Form: drops, ophthalmic/otic
Active substance Dosage ciprofloxacin 3.0 mg dexamethasone 1.0 mg ATC: S03CA01
Manufacturer: Centiss Pharma Pvt. Ltd.
-
The drug is used to treat non-infectious inflammatory diseases of the anterior segment of the eye.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: ExcelVision
-
The drug is used to treat a wide range of diseases: from endocrine disorders (adrenal insufficiency) and rheumatological diseases (arthritis) to allergic reactions, skin diseases, eye diseases, and respiratory tract diseases. It is also used for the treatment of COVID-19 in adults and adolescents requiring supplemental oxygen therapy, as well as to reduce cerebral edema and in certain types of shock.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
Manufacturer: PJSC "Lekhim - Kharkiv"
-
The drug is used to treat a wide range of diseases: endocrine disorders, rheumatic diseases (e.g., rheumatoid arthritis), systemic connective tissue diseases, allergic reactions, diseases of the skin, eyes, gastrointestinal tract, and respiratory tract. It is also used in certain hematological, oncological, and neurological diseases, as well as for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen therapy.
Form: tablets
Active substance Dosage dexamethasone 0.5 mg ATC: H02AB02
Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat a wide range of conditions: endocrine disorders (e.g., adrenal insufficiency), rheumatic diseases, allergic reactions, skin diseases, eye inflammations, gastrointestinal diseases (such as ulcerative colitis or Crohn's disease), as well as for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen support.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
Manufacturer: LLC "Research Plant "GNCLS" (quality control, batch release)
-
The drug is used to treat a wide range of diseases: endocrine disorders (e.g., adrenal insufficiency), rheumatological diseases (arthritis, osteoarthritis), allergic reactions, diseases of the skin, eyes, gastrointestinal tract, and respiratory tract. It is also used in certain types of cancer, cerebral edema, shock states, and for the treatment of COVID-19 in adults and adolescents requiring oxygen support.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
-
The drug is used to treat a wide range of diseases: endocrine disorders (e.g., adrenal insufficiency), rheumatic diseases (arthritis), systemic connective tissue diseases, allergic reactions, diseases of the skin, eyes, gastrointestinal tract, and respiratory tract, as well as certain hematological, oncological, and renal diseases.
Form: tablets
Active substance Dosage dexamethasone 0.5 mg ATC: H02AB02
-
The drug is used to treat allergic and non-infectious inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye, specifically for relieving inflammation after surgery.
Form: drops, ophthalmic, suspension
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: Rompharm Company SRL (manufacturing, primary packaging, quality control (physico-chemical) and batch release)
-
The drug is used for the palliative treatment of tumors, as well as for the prevention and treatment of vomiting induced by chemotherapy (in combination with antiemetic agents).
Form: tablets
Active substance Dosage dexamethasone 20 mg ATC: H02AB02
-
The drug is used for the palliative treatment of tumors, as well as for the prevention and treatment of vomiting induced by chemotherapy.
Form: tablets
Active substance Dosage dexamethasone 40 mg ATC: H02AB02
-
The drug is used to treat cerebral edema, severe asthma attacks, acute skin diseases, autoimmune disorders (e.g., systemic lupus erythematosus), rheumatoid arthritis, as well as for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen therapy. It is also used in the palliative treatment of tumors and for the prevention of vomiting after surgery or chemotherapy.
Form: tablets
Active substance Dosage dexamethasone 4 mg ATC: H02AB02
-
The drug is used to treat cerebral edema, severe asthma attacks, acute skin diseases, autoimmune disorders (e.g., systemic lupus erythematosus), rheumatoid arthritis, as well as for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen therapy. It is also used in the palliative treatment of tumors and for the prevention of vomiting after surgery or chemotherapy.
Form: tablets
Active substance Dosage dexamethasone 8 mg ATC: H02AB02
-
The drug is used to treat a wide range of diseases: endocrine disorders, rheumatological diseases (e.g., rheumatoid arthritis), skin diseases (psoriasis, dermatitis), allergic reactions, inflammatory eye diseases, gastrointestinal diseases (Crohn's disease, ulcerative colitis), as well as cerebral edema, shock states, and certain oncological diseases. It is also indicated for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen therapy.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat allergic and non-infectious inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye, specifically to relieve inflammation after surgery.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat a wide range of diseases: endocrine disorders, rheumatological diseases (e.g., arthritis), allergic reactions, diseases of the skin, eyes, gastrointestinal tract, and respiratory tract. It is also used in the treatment of COVID-19 in adults and adolescents (from 12 years of age weighing at least 40 kg) who require supplemental oxygen therapy.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat a wide range of diseases: allergic conditions (asthma, dermatitis, rhinitis), skin diseases, endocrine disorders, gastrointestinal diseases (Crohn's disease, colitis), hematological, oncological, neurological, and rheumatic diseases. It is also used for the treatment of COVID-19 in adults and adolescents (from 12 years of age weighing 40 kg or more) who require supplemental oxygen therapy.
Form: tablets
Active substance Dosage dexamethasone 0.5 mg ATC: H02AB02
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat allergic and non-infectious inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye, particularly in post-operative inflammation.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: FZ "STADA" LLC
-
The drug is used to treat non-infectious inflammatory diseases of the anterior segment of the eye.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: Excelvision (manufacturing, primary and secondary packaging, batch control)
-
The drug is used to treat severe non-infectious eye inflammation, such as allergic diseases, inflammation of the conjunctiva, cornea, and anterior segment of the eye, as well as for the prevention and treatment of post-operative inflammation.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: URSAPHARM Arzneimittel GmbH
-
The drug is intended for adults for the prevention and treatment of inflammation, as well as to prevent infections that may occur after cataract removal surgery.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 1 mg/ml levofloxacin 5 mg/ml ATC: S01CA01
Manufacturer: Santen AG (manufacturer, responsible for batch release)
-
The drug is used to treat steroid-responsive allergic and non-infectious inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye, particularly for relieving inflammation after surgery.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: Farmak JSC
-
The drug is used to treat non-infectious allergic and inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye that are steroid-responsive, particularly for relieving inflammation after surgery.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: Novartis Manufacturing NV
-
The drug is used to treat inflammation of the ocular tissues that is accompanied by or carries a risk of bacterial infection. This includes inflammation of the conjunctiva, cornea, and other parts of the eye, as well as lesions following burns or the presence of foreign bodies.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml neomycin 3500 IU/ml polymyxin b 6000 IU/ml ATC: S01CA01
Manufacturer: Alcon Coutier
-
The drug is used to treat eye inflammation accompanied by bacterial infection or the risk of its development. This includes cases following surgical interventions, injuries, or the presence of a foreign body in the eye.
Form: drops, ophthalmic, suspension
Active substance Dosage tobramycin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: K.O. ROMFARM COMPANY S.R.L.
-
The drug is used to treat non-infectious inflammatory and allergic conditions of the conjunctiva, cornea, and anterior segment of the eye, specifically for relieving inflammation after surgery.
Form: drops, ophthalmic, suspension
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: K.O. Rompharm Company S.R.L.
-
The drug is used to treat allergic and non-infectious inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye, specifically for relieving inflammation after surgery.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used to treat inflammation of the eye tissues (e.g., conjunctivitis, keratitis) where there is a risk or presence of bacterial infection. It is also used for acute and chronic external otitis and acute middle otitis (if the eardrum is intact).
Form: drops, ophthalmic/otic, suspension
Active substance Dosage dexamethasone 1 mg neomycin 3.5 mg polymyxin b 6000 IU ATC: S01CA01
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used to treat allergic and vernal conjunctivitis, blepharitis, blepharo-conjunctivitis, allergic keratoconjunctivitis, as well as scleritis, episcleritis, and uveitis.
Form: drops, ophthalmic solution
Active substance Dosage dexamethasone 0.342 mg ATC: S01BA01
Manufacturer: Farmigea S.p.A.
-
The drug is used to treat non-purulent inflammatory and allergic eye diseases, such as conjunctivitis, keratitis, iritis, iridocyclitis, as well as corneal injuries, marginal ulcers, and postoperative conditions.
Form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC: S01BA01
Manufacturer: Santen AG (manufacturer, responsible for batch release)
-
The drug is used to treat inflammatory eye diseases accompanied by superficial bacterial infection, as well as to relieve inflammation in the postoperative period.
Form: drops, ophthalmic, suspension
Active substance Dosage ciprofloxacin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: Farmak JSC
-
The drug is used for the treatment of adult patients with macular edema (resulting from central or branch retinal vein occlusion), non-infectious uveitis (inflammation of the posterior segment of the eye), as well as diabetic macular edema, if other treatment methods are unsuitable or ineffective.
Form: implant, intravitreal
Active substance Dosage dexamethasone 700 mcg ATC: S01BA01
Manufacturer: Allergan Pharmaceuticals Ireland
-
The drug is used for the local treatment of bacterial otitis externa (provided the eardrum is intact), as well as for infectious eczema of the ear canal.
Form: drops, otic solution
Active substance Dosage neomycin 10 mg polymyxin b 10000 IU dexamethasone 1 mg ATC: S02CA06
Manufacturer: Farmaster
-
The drug is used to treat inflammatory and infectious diseases of the nasal cavity, particularly acute rhinitis and acute sinusitis.
Form: spray, nasal solution
Active substance Dosage neomycin 6500 IU/ml polymyxin b 10000 IU/ml dexamethasone 0.25 mg/ml phenylephrine 2.5 mg/ml ATC: R01AD53
Manufacturer: Sofarteks
-
The drug is used to treat a wide range of conditions: cerebral edema, severe asthma attacks, anaphylactic shock, polytrauma shock, as well as for the therapy of autoimmune, rheumatological, and certain infectious diseases. It is also used for the treatment of COVID-19 in adults and adolescents (from 12 years old) who require supplemental oxygen, as well as for the local treatment of inflammation of the joints and eyes.
Form: solution for injection
Active substance Dosage dexamethasone 4 mg/ml ATC: H02AB02
Manufacturer: Farmak JSC
-
The drug is used to treat eye inflammation if it is accompanied by a bacterial infection or the risk of its development. This may occur following injuries, the presence of a foreign body in the eye, or surgical interventions.
Form: drops, ophthalmic, suspension
Active substance Dosage tobramycin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: JSC "Kyiv Vitamin Plant" (manufacturing of bulk products for RAFARMS S.A., Greece)
-
The drug is used to treat eye inflammation accompanied by bacterial infection or the risk of its development. This includes cases following surgical interventions, injuries, or the presence of a foreign body in the eye.
Form: drops, ophthalmic
Active substance Dosage tobramycin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: Novartis Manufacturing NV
-
The drug is used to treat eye inflammations accompanied by bacterial infection or the risk of its development. This includes cases following surgical interventions (e.g., cataract removal), eye injuries, or the presence of a foreign body.
Form: ointment, ophthalmic
Active substance Dosage tobramycin 3 mg/g dexamethasone 1 mg/g ATC: S01CA01
Manufacturer: Novartis Manufacturing NV
-
The drug is used to treat eye inflammations accompanied by bacterial infection or the risk of its development. This may include inflammatory processes following surgical interventions, injuries, or the presence of a foreign body in the eye.
Form: drops, ophthalmic, suspension
Active substance Dosage tobramycin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: Warsaw Pharmaceutical Plant Polfa JSC
-
The drug is used to treat eye inflammation if it is accompanied by a bacterial infection or the risk of its development. This may include conditions following surgical interventions, injuries, or the presence of a foreign body in the eye.
Form: drops, ophthalmic, suspension
Active substance Dosage tobramycin 3 mg/ml dexamethasone 1 mg/ml ATC: S01CA01
Manufacturer: RAFARM SA
-
The drug is used to treat eye inflammation if it is accompanied by a superficial bacterial infection or if there is a risk of its development. This may include post-operative conditions (e.g., cataract removal), eye injuries, or the presence of a foreign body.
Form: ointment, ophthalmic
Active substance Dosage tobramycin 3 mg dexamethasone 1 mg ATC: S01CA01
Manufacturer: BALKANFARMA-RAZGRAD AD